Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Gamida Cell Ltd. Transaction History

Yahav Achim Ve Achayot Provident Funds Management CO Ltd.

  • $35.2 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 17, 2021
BUY
$3.85 - $6.44 $673,750 - $1.13 Million
175,000 New
175,000 $686,000

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Yahav Achim Ve Achayot Provident Funds Management CO Ltd. Portfolio

Follow Yahav Achim Ve Achayot Provident Funds Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yahav Achim Ve Achayot Provident Funds Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yahav Achim Ve Achayot Provident Funds Management CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email